[Changed levels of substance P and somatostatin in HIV-positive children] - PubMed (original) (raw)
. 1992 Nov-Dec;14(6):577-81.
[Article in Italian]
Affiliations
- PMID: 1284355
[Changed levels of substance P and somatostatin in HIV-positive children]
[Article in Italian]
C Azzari et al. Pediatr Med Chir. 1992 Nov-Dec.
Abstract
Substance P (sP) and Somatostatin (SOM), so as other neuropeptides can modulate neurologic and immunologic functions. sP has been described to enhance both in vitro and in vivo immunoglobulin synthesis. On the contrary, SOM has an inhibitory effect on the same activity. The modulating effect is more evident on IgA isotype. Hypergammaglobulinemia and in particular high levels of IgA is a common finding in pediatric AIDS and an imbalance among regulatory effects of neuropeptides might be suggested. In order to evaluate the plasma levels of sP in pediatric AIDS we studied 15 children with HIV infection (status P2), 10 seronegative children born to HIV positive mothers and 10 healthy children of the same age. All the HIV positive children had high plasma levels of IgG and IgA. The plasma level of sP was extremely higher in HIV positive children while no significant difference was found between seronegative children born to HIV positive mothers and healthy children. SOM was decreased in HIV positive children when compared to control groups but a significant difference was not reached. It might be supposed that HIV infection, through a dysregulation among neuropeptides interferes on immune functions and in particular on IgA synthesis. On the other hand it might be suggested that the imbalance between sP and SOM depends on the viral infection of immune cells since it has been demonstrated that SOM and other neuropeptide are synthesized by lymphoid tissue. Further studied relevance of neuropeptide disorders in pediatric AIDS.
Similar articles
- Immunoglobulin profile in HIV-1 infected children in Dar es Salaam.
Lyamuya EF, Matee MI, Kasubi M, Scheutz F. Lyamuya EF, et al. East Afr Med J. 1999 Jul;76(7):370-5. East Afr Med J. 1999. PMID: 10520363 - Relation between stressful life events, neuropeptides and cytokines: results from the LISA birth cohort study.
Herberth G, Weber A, Röder S, Elvers HD, Krämer U, Schins RP, Diez U, Borte M, Heinrich J, Schäfer T, Herbarth O, Lehmann I; LISAplus study group. Herberth G, et al. Pediatr Allergy Immunol. 2008 Dec;19(8):722-9. doi: 10.1111/j.1399-3038.2008.00727.x. Epub 2008 Feb 25. Pediatr Allergy Immunol. 2008. PMID: 18312535 - Pediatric AIDS and perinatal HIV infection in Zaire: epidemiologic and pathologic findings.
Nelson AM, Firpo A, Kamenga M, Davachi F, Angritt P, Mullick FG. Nelson AM, et al. Prog AIDS Pathol. 1992;3(1):1-33. Prog AIDS Pathol. 1992. PMID: 1606299 Review. - Substance P and neurokinin-1 receptor modulation of HIV.
Ho WZ, Douglas SD. Ho WZ, et al. J Neuroimmunol. 2004 Dec;157(1-2):48-55. doi: 10.1016/j.jneuroim.2004.08.022. J Neuroimmunol. 2004. PMID: 15579279 Review.
Cited by
- Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro.
Wang X, Douglas SD, Lai JP, Tuluc F, Tebas P, Ho WZ. Wang X, et al. J Neuroimmune Pharmacol. 2007 Mar;2(1):42-8. doi: 10.1007/s11481-006-9059-6. Epub 2007 Jan 12. J Neuroimmune Pharmacol. 2007. PMID: 18040825 - Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor.
Schwartz L, Spitsin SV, Meshki J, Tuluc F, Douglas SD, Wolfe JH. Schwartz L, et al. J Neurovirol. 2013 Jun;19(3):219-27. doi: 10.1007/s13365-013-0166-x. Epub 2013 Jun 14. J Neurovirol. 2013. PMID: 23765222 Free PMC article. - Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.
Lai JP, Ho WZ, Zhan GX, Yi Y, Collman RG, Douglas SD. Lai JP, et al. Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3970-5. doi: 10.1073/pnas.071052298. Proc Natl Acad Sci U S A. 2001. PMID: 11274418 Free PMC article. - Neurokinin-1 receptor antagonist (aprepitant) suppresses HIV-1 infection of microglia/macrophages.
Wang X, Douglas SD, Song L, Wang YJ, Ho WZ. Wang X, et al. J Neuroimmune Pharmacol. 2008 Dec;3(4):257-64. doi: 10.1007/s11481-008-9117-3. Epub 2008 Jul 25. J Neuroimmune Pharmacol. 2008. PMID: 18654860 Free PMC article. - Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction.
Rumbaugh JA, Steiner J, Sacktor N, Nath A. Rumbaugh JA, et al. Futur HIV Ther. 2008;2(3):271-280. doi: 10.2217/17469600.2.3.271. Futur HIV Ther. 2008. PMID: 19774095 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous